Case Report
BibTex RIS Cite

A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome

Year 2025, Issue: Early Access
https://doi.org/10.18678/dtfd.1705026

Abstract

Denys-Drash syndrome (DDS) is a rare autosomal dominant disorder characterized by genital abnormalities, nephropathy, and Wilms’ tumor (WT), typically caused by heterozygous mutations in the Wilms’ tumor suppressor 1 (WT1) gene. Here, a 2-year-old male admitted with fever and abdominal pain was presented. Physical examination revealed ambiguous genitalia and a palpable abdominal mass. Imaging identified a heterogeneous mass in the left kidney, consistent with WT. Genetic analysis detected a novel heterozygous frameshift mutation in exon 8 of the WT1 gene [p.H245Tfs*2 (c.1393delC)]. WT is the most common renal tumor in children and is frequently associated with WT1 gene mutations in DDS. Given the early onset and severity of symptoms, early genetic screening for WT1 gene mutations should be considered in patients admitted with ambiguous genitalia and nephrotic syndrome. This case contributes to the understanding of WT1 gene mutations and highlights the importance of molecular analysis in children with genitourinary anomalies.

References

  • Glénisson M, Grapin M, Blanc T, Preka E, Hogan J, Aurelle M, et al. Genotype-phenotype correlations in Denys-Drash syndrome in children. Kidney Int Rep. 2025;10(4):1205-12.
  • Lopez-Gonzalez M, Ariceta G. WT1-related disorders: more than Denys-Drash syndrome. Pediatr Nephrol. 2024;39(9):2601-9.
  • Wang F, Cai J, Wang J, He M, Mao J, Zhu K, et al. A novel WT1 gene mutation in a Chinese girl with Denys-Drash syndrome. J Clin Lab Anal. 2021;35(5):e23769.
  • Guaragna MS, Ledesma FL, Manzano VZ, Maciel-Guerra AT, Guerra-Júnior G, Silva MM, et al. Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region. J Pediatr Endocrinol Metab. 2022;35(6):837-43.
  • Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 1990;61(7):1257-69.
  • Guaragna MS, Ribeiro de Andrade JG, de Freitas Carli B, Belangero VM, Maciel-Guerra AT, Guerra-Júnior G, et al. WT1 haploinsufficiency supports milder renal manifestation in two patients with Denys-Drash syndrome. Sex Dev. 2017;11(1):34-9.
  • Hakan N, Aydin M, Erdogan O, Cavusoglu YH, Aycan Z, Ozaltin F, et al. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome. Genet Couns. 2012;23(2):255-61.
  • Yue Z, Pei Y, Sun L, Huang W, Huang H, Hu B, et al. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children. Ren Fail. 2011;33(9):910-4.
  • da Silva TE, Nishi MY, Costa EM, Martin RM, Carvalho FM, Mendonca BB, et al. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. Pediatr Nephrol. 2011;26(8):1311-5.
  • Mendes E, Yaylak D, Sincer Y, Gurkan Y. Sacral erector spinae plane block for hypospadias surgery in a patient with Denys-Drash syndrome: A case report. A A Pract. 2025;19(6):e01989.
  • Shirinova N, Yalçın FZ, Tuğ Bozdoğan S. Current approach to genetic causes of female infertility and genetic counseling. Duzce Med J. 2022;24(S1):56-62.
  • Alfaifi J. miRNAs role in Wilms tumor pathogenesis: Signaling pathways interplay. Pathol Res Pract. 2024;256:155254.
  • Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, et al. Wilms tumour. Nat Rev Dis Primers. 2021;7(1):75.
  • Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, et al. Quality assessment for Wilms’ tumor: a report from the National Wilms’ Tumor Study-5. J Pediatr Surg. 2005;40:208-13.
  • Finn LS. Nephrotic syndrome throughout childhood: diagnosing podocytopathies from the womb to the dorm. Pediatr Dev Pathol. 2024;27(5):426-58.
  • Nagano C, Nozu K. A review of the genetic background in complicated WT1-related disorders. Clin Exp Nephrol. 2025;29(1):1-9.
  • Chen H, Zhang M, Lin J, Lu J, Zhong F, Zhong F, et al. Genotype-phenotype correlation of WT1 mutation-related nephropathy in Chinese children. Front Pediatr. 2023;11:1192021.

Denys-Drash Sendromunda WT1 Geninde Yeni Tanımlanan Bir Mutasyon

Year 2025, Issue: Early Access
https://doi.org/10.18678/dtfd.1705026

Abstract

Denys-Drash sendromu (DDS), genital anormallikler, nefropati ve Wilms tümörü (WT) ile karakterize, tipik olarak Wilms tümör baskılayıcı 1 (WT1) genindeki heterozigot mutasyonların neden olduğu nadir görülen otozomal dominant bir hastalıktır. Bu yazıda ateş ve karın ağrısı ile başvuran 2 yaşında bir erkek hasta sunulmuştur. Fizik muayenede belirsiz genital organlar ve karında ele gelen bir kitle saptandı. Görüntülemede sol böbrekte WT ile uyumlu heterojen bir kitle tespit edildi. Genetik analizde WT1 geninin 8. ekzonunda yeni bir heterozigot çerçeve kayması mutasyonu tespit edildi [p.H245Tfs*2 (c.1393delC)]. WT çocuklarda en sık görülen böbrek tümörüdür ve DDS'de sıklıkla WT1 gen mutasyonları ile ilişkilidir. Semptomların erken başlangıcı ve ciddiyeti göz önüne alındığında, belirsiz genital organlar ve nefrotik sendrom ile başvuran hastalarda WT1 gen mutasyonları için erken genetik tarama düşünülmelidir. Bu vaka, WT1 gen mutasyonlarının anlaşılmasına katkıda bulunmakta ve genitoüriner anomalileri olan çocuklarda moleküler analizin önemini vurgulamaktadır.

References

  • Glénisson M, Grapin M, Blanc T, Preka E, Hogan J, Aurelle M, et al. Genotype-phenotype correlations in Denys-Drash syndrome in children. Kidney Int Rep. 2025;10(4):1205-12.
  • Lopez-Gonzalez M, Ariceta G. WT1-related disorders: more than Denys-Drash syndrome. Pediatr Nephrol. 2024;39(9):2601-9.
  • Wang F, Cai J, Wang J, He M, Mao J, Zhu K, et al. A novel WT1 gene mutation in a Chinese girl with Denys-Drash syndrome. J Clin Lab Anal. 2021;35(5):e23769.
  • Guaragna MS, Ledesma FL, Manzano VZ, Maciel-Guerra AT, Guerra-Júnior G, Silva MM, et al. Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region. J Pediatr Endocrinol Metab. 2022;35(6):837-43.
  • Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 1990;61(7):1257-69.
  • Guaragna MS, Ribeiro de Andrade JG, de Freitas Carli B, Belangero VM, Maciel-Guerra AT, Guerra-Júnior G, et al. WT1 haploinsufficiency supports milder renal manifestation in two patients with Denys-Drash syndrome. Sex Dev. 2017;11(1):34-9.
  • Hakan N, Aydin M, Erdogan O, Cavusoglu YH, Aycan Z, Ozaltin F, et al. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome. Genet Couns. 2012;23(2):255-61.
  • Yue Z, Pei Y, Sun L, Huang W, Huang H, Hu B, et al. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children. Ren Fail. 2011;33(9):910-4.
  • da Silva TE, Nishi MY, Costa EM, Martin RM, Carvalho FM, Mendonca BB, et al. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. Pediatr Nephrol. 2011;26(8):1311-5.
  • Mendes E, Yaylak D, Sincer Y, Gurkan Y. Sacral erector spinae plane block for hypospadias surgery in a patient with Denys-Drash syndrome: A case report. A A Pract. 2025;19(6):e01989.
  • Shirinova N, Yalçın FZ, Tuğ Bozdoğan S. Current approach to genetic causes of female infertility and genetic counseling. Duzce Med J. 2022;24(S1):56-62.
  • Alfaifi J. miRNAs role in Wilms tumor pathogenesis: Signaling pathways interplay. Pathol Res Pract. 2024;256:155254.
  • Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, et al. Wilms tumour. Nat Rev Dis Primers. 2021;7(1):75.
  • Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, et al. Quality assessment for Wilms’ tumor: a report from the National Wilms’ Tumor Study-5. J Pediatr Surg. 2005;40:208-13.
  • Finn LS. Nephrotic syndrome throughout childhood: diagnosing podocytopathies from the womb to the dorm. Pediatr Dev Pathol. 2024;27(5):426-58.
  • Nagano C, Nozu K. A review of the genetic background in complicated WT1-related disorders. Clin Exp Nephrol. 2025;29(1):1-9.
  • Chen H, Zhang M, Lin J, Lu J, Zhong F, Zhong F, et al. Genotype-phenotype correlation of WT1 mutation-related nephropathy in Chinese children. Front Pediatr. 2023;11:1192021.
There are 17 citations in total.

Details

Primary Language English
Subjects Pediatric Nephrology
Journal Section Case Report
Authors

Nadide Melike Sav 0000-0003-1520-6426

Zeynep Canan Özdemir 0000-0002-9172-9627

Hüseyin Aslan 0000-0003-3542-4340

Muhsin Ozdemır 0000-0001-8088-937X

Bilal Yıldız, Md, Turkey 0000-0003-0110-439X

Ozcan Bor 0000-0002-1662-3259

Early Pub Date October 1, 2025
Publication Date October 2, 2025
Submission Date May 23, 2025
Acceptance Date September 6, 2025
Published in Issue Year 2025 Issue: Early Access

Cite

APA Sav, N. M., Özdemir, Z. C., Aslan, H., … Ozdemır, M. (2025). A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome. Duzce Medical Journal(Early Access). https://doi.org/10.18678/dtfd.1705026
AMA Sav NM, Özdemir ZC, Aslan H, Ozdemır M, Yıldız, Md, Turkey B, Bor O. A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome. Duzce Med J. October 2025;(Early Access). doi:10.18678/dtfd.1705026
Chicago Sav, Nadide Melike, Zeynep Canan Özdemir, Hüseyin Aslan, Muhsin Ozdemır, Bilal Yıldız, Md, Turkey, and Ozcan Bor. “A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome”. Duzce Medical Journal, no. Early Access (October 2025). https://doi.org/10.18678/dtfd.1705026.
EndNote Sav NM, Özdemir ZC, Aslan H, Ozdemır M, Yıldız, Md, Turkey B, Bor O (October 1, 2025) A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome. Duzce Medical Journal Early Access
IEEE N. M. Sav, Z. C. Özdemir, H. Aslan, M. Ozdemır, B. Yıldız, Md, Turkey, and O. Bor, “A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome”, Duzce Med J, no. Early Access, October2025, doi: 10.18678/dtfd.1705026.
ISNAD Sav, Nadide Melike et al. “A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome”. Duzce Medical Journal Early Access (October2025). https://doi.org/10.18678/dtfd.1705026.
JAMA Sav NM, Özdemir ZC, Aslan H, Ozdemır M, Yıldız, Md, Turkey B, Bor O. A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome. Duzce Med J. 2025. doi:10.18678/dtfd.1705026.
MLA Sav, Nadide Melike et al. “A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome”. Duzce Medical Journal, no. Early Access, 2025, doi:10.18678/dtfd.1705026.
Vancouver Sav NM, Özdemir ZC, Aslan H, Ozdemır M, Yıldız, Md, Turkey B, Bor O. A Newly Identified Mutation in the WT1 Gene in Denys-Drash Syndrome. Duzce Med J. 2025(Early Access).